A new report from a WMD expert raises disturbing questions. A bioweapons expert likely to head the Trump administration’s top Pentagon post for countering weapons of mass destruction has charged…[...]
Read More
Story by Science X staff Cohort overview and humoral immunity in healthy convalescent individuals and individuals with long COVID recruited from the United Kingdom. Credit: Nature Immunology (2025). DOI:10.1038/s41590-025-02135-5 Researchers at…[...]
Read More
As the global understanding of COVID-19 deepens, 2025 research has illuminated how SARS-CoV-2 affects blood morphology, particularly red blood cells (RBCs), hemoglobin function, and hematopoiesis. These changes are not only…[...]
Read More
Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), continues to affect millions globally, with shortness of breath and impaired gas exchange among its most persistent symptoms. Recent peer-reviewed studies…[...]
Read More
By Sandy Fitzgerald | NewsMax The Food and Drug Administration is still determining whether it will approve COVID-19 vaccines for next winter, as there is a lack of data on the booster shots,…[...]
Read More
Five years after the launch of the global COVID-19 vaccination campaign, questions persist about the role of news organizations, federal health agencies, and the Biden administration in shaping public perception…[...]
Read More
Five years into the pandemic, shortness of breath remains one of the most persistent and debilitating symptoms of Long COVID, affecting millions globally. This article synthesizes findings from 2025 peer-reviewed…[...]
Read More
BMJ 2024; 387 doi: https://doi.org/10.1136/bmj-2024-081318, Cite this as: BMJ 2024;387:e081318 Abstract Objective To compare the effectiveness of interventions for the management of long covid (post-covid condition). Design Living systematic review. Data sources Medline, Embase, CINAHL, PsycInfo, Allied and Complementary…[...]
Read More
Authored by Zachary Stieber & Jan Jekielek via The Epoch Times The commissioner of the Food and Drug Administration is responding to critics of the agency’s recent approvals of COVID-19…[...]
Read More
ConditionObserved IncreaseVaccine TypeMyocarditis (heart inflammation)Up to 2.6× higher after 4th mRNA dosePfizer, ModernaPericarditis (heart lining)~1.7× higher after 1st dosemRNA vaccinesGuillain-Barré Syndrome190 cases observed vs. 66 expectedAstraZenecaCerebral venous sinus thrombosis3.2× higher…[...]
Read More